• Explore /
  • Poster
  • / Preliminary results of sequential transarterial chemoembolization and stereotactic body radiotherapy followed by immunotherapy using single tremelimumab regular interval durvalumab in locally advanced, unresectable hepatocellular carcinoma (START-FIT using STRIDE): A single-arm, phase II study.

Preliminary results of sequential transarterial chemoembolization and stereotactic body radiotherapy followed by immunotherapy using single tremelimumab regular interval durvalumab in locally advanced, unresectable hepatocellular carcinoma (START-FIT using STRIDE): A single-arm, phase II study.

Abstract Poster

Authors

null

Chi Leung Chiang

The University of Hong Kong, Hong Kong, NA, Hong Kong

Chi Leung Chiang , Stephen Lam Chang , Sik-Kwan Chan , Ann Shing Lee , Keith Wan Hang Chiu , Vanessa Ting Yan Yeung , Natalie Sean Man Wong , Venus Wan Yan Lee , Vince Wing Hang Lau , Nancy Kwan Man , Feng-Ming Spring Kong , Albert Chi Yan Chan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer - Local-Regional Disease

Clinical Trial Registration Number

NCT04988945

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4124)

DOI

10.1200/JCO.2023.41.16_suppl.4124

Abstract #

4124

Poster Bd #

445

Abstract Disclosures

Similar Posters

First Author: Chi Leung Chiang

First Author: Guoliang Shao

First Author: Xiang Nong

First Author: Kazuomi Ueshima